G Medical Innovations Holdings Limited EBIT

G Medical Innovations Holdings Limited (GMVD) currently reports a EBIT of $6.1M as of December 2021. That compares with $-20M in the prior-year period — up 130.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore G Medical Innovations Holdings Limited's EBIT history and peer comparisons.

G Medical Innovations Holdings Limited's EBIT increased from $-20M to $6.1M — a 130.8% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

G Medical Innovations Holdings Limited's EBIT of $6.1M is lower than the Healthcare sector average of $23B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

G Medical Innovations Holdings Limited reported $6.1M in EBIT as of December 2021. That compares with $-20M in the prior-year period — up 130.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $6.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for G Medical Innovations Holdings Limited, and consider following GMVD for alerts when major investors trade the stock.